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Background & Aims: The mechanisms of liver injury in
chronic hepatitis C virus (HCV) infection are poorly
understood. Indirect evidence suggests that oxidative
stress and mitochondrial injury play a role. The aim of
this study was to determine if the HCV core protein itself
alters mitochondrial function and contributes to oxida-
tive stress. Methods: HCV core protein was expressed in
3 different cell lines, and reactive oxygen species (ROS)
and lipid peroxidation products were measured. Results:
Core expression uniformly increased ROS. In 2 inducible
expression systems, core protein also increased lipid
peroxidation products and induced antioxidant gene ex-
pression as well. A mitochondrial electron transport in-
hibitor prevented the core-induced increase in ROS. A
fraction of the expressed core protein localized to the
mitochondria and was associated with redistribution of
cytochrome c from mitochondrial to cytosolic fractions.
Sensitivity to oxidative stress was also seen in HCV
transgenic mice in which increased intrahepatic lipid
peroxidation products occurred in response to carbon
tetrachloride. Conclusions: Oxidative injury occurs as a
direct result of HCV core protein expression both in vitro
and in vivo and may involve a direct effect of core
protein on mitochondria. These results provide new in-
sight into the pathogenesis of hepatitis C and provide an
experimental rationale for investigation of antioxidant
therapy.
Infection with hepatitis C virus (HCV) is a leadingcause of chronic hepatitis, and current therapy results
in viral elimination in fewer than 50% of individuals.1
The mechanisms underlying HCV-associated liver cell
injury are not well understood; in particular, the relative
contributions of immune and direct viral effects are not
known. Oxidative stress, imposed either directly by the
virus or by the host-immune response, has been sug-
gested as a potentially important pathologic mechanism
in hepatitis C as well as other chronic liver diseases.2
Liver tissue from HCV-infected patients shows evidence
of glutathione depletion, morphologic changes in mito-
chondria,3 and the presence of lipid peroxide–protein
adducts.4 Plasma samples also show increased lipid per-
oxidation products,5 and peripheral blood mononuclear
cells from hepatitis C virus (HCV)–infected patients
contain elevated superoxide dismutase activity,6 consis-
tent with a response to increased cellular reactive oxygen
species (ROS). A link between oxidative stress and
pathogenesis is also supported by a pilot study of anti-
oxidant therapy that suggested improvements in liver
injury in chronic hepatitis C.7
Despite this evidence, little is understood about the
mechanisms that produce oxidative stress in chronic
hepatitis C. We show that HCV core protein alters
mitochondrial function and results directly in an increase
in the cellular abundance of ROS with consequent in-
creases in cellular lipid peroxidation. These results pro-
vide new insight into how HCV infection leads to he-
patic injury, and provide a firm theoretical basis for the
investigation of antioxidant therapies in this important
disease.
Materials and Methods
Cell Lines
Human hepatoma Huh-7 cells were maintained in
Dulbecco modified Eagle medium supplemented with 10%
heat-inactivated fetal bovine serum, penicillin G (100 U/mL),
streptomycin (100 U/mL; Gibco-BRL, Rockville, MD) in a
humidified 37°C/5% CO2 incubator. HeLa Tet-Off cells
(Clontech, Palo Alto, CA) were cultured in the same medium
except for the addition of 100 mg/mL G418. The complemen-
tary DNA (cDNA) fragment encoding full-length HCV core
Abbreviations used in this paper: CM-DCF, chloromethyl 2*,7*-dichlo-
rodihydrofluorescein diacetate; DPI, diphenyliodonium; ER, endoplas-
mic reticulum; MPT, mitochondrial permeability transition; ROS, reac-
tive oxygen species.
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protein of an infectious cDNA clone (genotype 1b)8 was in-
serted into pTRE2 (Clontech) to generate pTRE2-191. Cells
were cotransfected with pTet-Off (Clontech) and pTRE2-191
(Huh-7) or pTRE2-191 and pTK-Hyg (Clontech; HeLa), fol-
lowed by selection with 400 mg/mL G418 (Huh-7) or 200
mg/mL hygromycin (HeLa) and 1 mg/mL tetracycline (Sigma-
Aldrich, St. Louis, MO). G418-resistant Huh-7 clones and
G418/hygromycin double-resistant HeLa clones were exam-
ined for core protein expression upon withdrawal of tetracy-
cline by immunofluorescence microscopy and immunoblot
analysis. A Huh-7 clone (191-20) and a HeLa clone (191-14)
with tight conditional expression of core were selected for
further study.
Measurement of Cellular DNA Content
Huh-7 191-20 cells were seeded in T-175 flasks at a
density of 5 3 105 cells and grown to 80% confluence for 5
days in the presence or absence of tetracycline. Cells were
trypsinized, and cell cycle distribution was determined by
propidium iodide staining for DNA content followed by flow
cytometry as described previously.9 Briefly, 2.5 3 106 cells
were pelleted and washed with cold phosphate-buffered saline
(PBS)/azide solution (PBS plus 0.1% sodium azide). Cells were
resuspended in 1 mL of low-salt staining buffer (3% PEG
8000 [wt/vol], 50 mg/mL propidium iodide, 180 U/mL
RNAse A, 0.1% (vol/vol) Triton X-100, 4 mmol/L sodium
citrate) and incubated at 37°C for 20 minutes. One milliliter
of high-salt staining buffer (3% PEG 8000 [wt/vol], 50
mg/mL propidium iodide, 180 U/mL RNAse A, 0.1% [vol/
vol] Triton X-100, 400 mmol/L sodium chloride) was added to
the cells followed by incubation at 4°C overnight. Stained
nuclei were analyzed by flow cytometry on a Becton-Dickinson
(San Jose, CA) FACScan flow cytometer. Percentages of cells in
various stages of the cell cycle were determined using the
WinMDI 2.8 flow cytometry software package.
Measurement of ROS
Cells were plated onto glass coverslips and examined
for ROS production 72 hours after removal of tetracycline.
They were loaded for 2 hours with chloromethyl 29,79-dichlo-
rodihydrofluorescein diacetate (CM-DCF; Molecular Probes,
Inc., Eugene, OR) at a final concentration of 10 mmol/L.
Fluorescence was measured by quantitative single-cell fluores-
cence microscopy at 495 nm/535 nm (excitation/emission)
using an Image-1/FL analysis system as described previously.10
Results were expressed as relative fluorescence intensity and
normalized to control cells. In some experiments, ROS was
measured after addition of diphenyliodonium (100 mmol/L;
Aldrich, Milwaukee, WI) or cyclosporin A (5 mmol/L; Sigma).
Measurement of LPO Products
Appropriate cell cultures (2–4 3 107 cells) or tissue
homogenates (200 mg liver tissue) were prepared by sonica-
tion and stored at 270°C with 5 mmol/L butylated-hydroxy-
toluene (Sigma). For cells expressing core protein, samples
were obtained 72 hours after removal of tetracycline. 4-Hy-
droxyalkenals and malondialdehyde were measured in these
homogenates using a commercial assay (LPO-586; OXIS In-
ternational Inc., Portland, OR). Protein concentration was
determined by the Coomassie assay (Pierce, Rockford, IL).
Carbon Tetrachloride Treatment
of Transgenic Mice
Transgenic mice (S-N/863 lineage) were used. These
mice are a heterozygous model and express the HCV structural
proteins (core, E1, and E2p7) in hepatocytes under the control
of the murine albumin enhancer/promoter. Their characteris-
tics are described in detail in this issue of GASTROENTEROLOGY
(Lerat et al. 2002;122:352–365). Transgenic mice and their
normal C57BL/6 littermates were injected intraperitoneally
with 20 mL/kg of CCl4 (Aldrich, Milwaukee, WI) in olive oil.
Control mice were injected with an equal volume of olive oil.
Animals were killed 24 hours after CCl4 injection, and liver
tissue and blood samples were collected for determination of
histology, lipid peroxidation products, and alanine amino-
transferase. All procedures were approved by and carried out in
accordance with the policies of the Institutional Animal Care
and Use Committee of the University of Texas Medical
Branch.
Fluorescence Microscopy
Cells were grown on plastic culture slides and incu-
bated at 37°C for 30 minutes with MitoTracker Red (50
nmol/L; Molecular Probes, Inc.). Cells were fixed in 3.7%
paraformaldehyde and permeabilized with 0.25% saponin in
PBS. Fixed cells were subsequently incubated with mouse
monoclonal anti-hepatitis C core antibody (Affinity Bioreagents,
Golden, CO) at a dilution of 1:350 for 2 hours at room
temperature and with Alexa Fluor 488 goat anti-mouse IgG
(Molecular Probes, Inc.) at a dilution of 1:500 for 30 minutes
at 37°C and incubated with DAPI (1 mmol/L; Sigma) for 4
minutes. They were examined with a Nikon Eclipse epifluo-
rescence microscope or a Zeiss LSM-410 confocal microscope.
Mitochondrial permeability transition (MPT) was assessed by a
modification of the method described by Nieminen et al.11
Cells were loaded by exposure to rhodamine-123 (Molecular
Probes, Inc.) for 0.5–2 hours, perfused with Na-Ringers solu-
tion. pH 7.7, 37°C, and serially imaged with epifluorescence
microscopy at 12-min intervals. The onset of MPT was deter-
mined by the sudden loss of fluorescence from mitochondria.
Subcellular Fraction and Immunoblotting
Cells were suspended in HIM buffer12 supplemented
with 10 mL/mL of protease inhibitor cocktail (Sigma), homog-
enized with a tight-fitting Dounce homogenizer (25 strokes)
and centrifuged at 10,000g for 10 minutes to collect the crude
mitochondria. Purified mitochondria were prepared by Percoll
gradient centrifugation as described.13 The postmitochondrial
supernatant was centrifuged at 100,000g for 30 minutes to
obtain a cytosolic fraction.
For immunoblotting, samples were separated by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis on a 16%
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gel and electrophoretically blotted onto polyvinylidene diflu-
oride membranes (BioRad). Protein quantities applied were 50
mg of whole-cell lysate for detection of core; 2.5 mg of crude
mitochondrial and 17 mg of cytosolic fraction for detection of
cytochrome c; and 7 mg of both crude and pure mitochondrial
fractions for detection of core, coxII, and calnexin. Proteins
were detected with the enhanced chemiluminescence plus
Western blotting detection system (Amersham, Little Chal-
font, Buckinghamshire, England). Primary antibodies used
were mouse monoclonal anti-HCV core (Maine Biotechnology
Services, Inc., Portland , ME) at 1:25 dilution, mouse mono-
clonal anti–cytochrome c antibody (R & D Systems, Inc.,
Minneapolis, MN) at 1:2000 dilution, mouse monoclonal anti-
human cytochrome oxidase subunit II antibody (Molecular
Probes) at 1:500 dilution, and mouse monoclonal anti-calnexin
antibody (Affinity Bioreagents) at 1:500 dilution.
RNA Isolation and Analysis With High-
Density Oligonucleotide Arrays
High-density oligonucleotide arrays were probed with
biotinylated single-stranded antisense RNAs prepared from
total cellular RNA isolated from Huh-7 and Huh-7/191-20
cells before and after induction of HCV core protein expres-
sion. RNA was extracted using the RNAqueous RNA extrac-
tion kit (Ambion, Austin, TX) and used as a template for
probe synthesis in a reaction according to the manufacturer’s
protocol (Affymetrix, Santa Clara, CA). Biotinylated probes
were then hybridized to an Affymetrix human GeneChip
(Hu95A). The DNA arrays were scanned using an Affymetrix
confocal scanner (Algient), and the data were analyzed using
Microarray GeneSuite software 4.0.1. Only mRNAs that
showed a $3-fold differential regulation between cells express-
ing HCV core protein and those not expressing core protein
were selected for further analysis.
Statistical Analysis
Statistical analyses were carried out by unpaired or
paired t test as appropriate. All data are reported as means 6
SD or SE. A P value of ,0.05 was considered significant.
Results
Core Protein Expression in Inducible
Cell Lines
We developed clonal, stably transformed cell lines
from human hepatoma (Huh-7/191-20) and human cer-
vical carcinoma cells (HeLa/191-14) capable of condi-
tionally expressing the full-length HCV core protein
(amino acids 1–191) under control of the Tet-Off pro-
moter. Figure 1A shows the tight control of core protein
expression in both Huh-7/191-20 and HeLa/191-14
cells. In both cell lines there was no detectable core
protein when cells were cultured in the presence of
tetracycline, but strong core protein expression was de-
tected 72 hours after the withdrawal of tetracycline from
the culture medium. Maximal core protein expression in
Huh-7/191-20 cells was estimated by comparison of
Western blots with known quantities of synthetic core
protein (kindly provided by S. Watowich) and was ap-
proximately 60 ng core/mg cell protein.
To determine if core protein expression alters apopto-
sis or cell growth, we subjected cells to flow cyometric
measurement of DNA content. The results, shown in
Figure 1B, show no difference in the distribution of cells
through the cell cycle as a result of core protein expres-
sion. In particular, there was no change in the small
population of subdiploid cells, indicating that the inci-
dence of spontaneous apoptosis is small and not affected
by core protein expression. Furthermore, induction of
core protein did not alter cell growth rates as assessed by
cell counts in dividing cultures (Li et al., manuscript in
preparation).
Figure 1. HCV core protein expression and cellular DNA content. (A)
Huh-7/191-20 and HeLa/191-14 cells were cultured in the presence
(off) or absence (on) of tetracycline, and immunoblotting for HCV core
protein was performed on whole-cell lysate as described. The ex-
pected molecular weight for core protein (21 kilodaltons) is indicated.
(B) Cellular DNA content was measured by flow cytometry in Huh-7/
191-20 cells. There was no difference in the distribution of cells
through the cell cycle as a result of core protein expression.
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Core Protein Expression Increases
Cellular ROS
The ROS content of Huh-7/191-20 cells and
HeLa/191-14 cells was determined by a single-cell flu-
orescence assay before (off ) and after (on) the induction of
core protein expression. As shown in Figure 2A, the
expression of core increased the basal ROS content of
Huh-7/191-20 cells 3.4 6 0.05-fold (P , 0.001). As a
control, we also measured ROS in normal Huh-7 cells
after treatment with tumor necrosis factor a (100 ng/mL;
Endogen, Rockford, IL) and actinomycin D (0.5 mg/mL;
Sigma), a proapoptotic stimulus that has previously been
shown to produce apoptosis and oxidative stress in hepa-
tocytes.14 This treatment produced a 1.7-fold increase in
ROS content compared with control Huh-7 cells (P ,
0.001), less than that resulting from expression of core
protein. ROS abundance was also increased in HeLa/
191-14 cells upon induction of core protein expression
and in stably transformed Chinese hamster ovary (CHO-
K1) cells expressing core, E1, and E2p7 (P , 0.001) but
not in CHO-K1 cells expressing E1 and E2p7 only15
(Figure 2A ). Together, these results provide strong evi-
dence that ROS accumulation is caused specifically by
expression of the core protein.
We next quantified total cellular lipid peroxidation
products in extracts from these cells. This information
provides a measure of the consequences of oxidative stress
because peroxidation of lipids is a result of elevated
cellular ROS. The induction of core protein expression
resulted in a significant increase in the abundance of lipid
peroxide products in both Huh-7/191-20 and HeLa/
191-14 cells (Figure 2B). This result confirms that core
protein expression induces oxidative injury in these cells.
Role of Mitochondria in Core-Induced
ROS Production
ROS are generated as a consequence of mitochon-
drial electron transport caused by a small proportion of
the electron flow interacting with molecular oxygen be-
fore reaching the cytochrome oxidase complex.16 Mito-
chondria are the principal source of cellular ROS under
most conditions, and the mitochondrial component of
ROS production can be quantitatively inhibited by di-
phenyliodonium (DPI), an irreversible inhibitor of fla-
voenzymes that blocks electron transport through mito-
chondrial complex I17 and thus prevents mitochondrial
ROS production.18 Figure 3A shows that DPI treatment
(100 mmol/L) entirely inhibited the increase in cellular
ROS level that followed the induction of core protein.
Under these conditions there was no effect of DPI on cell
death as assessed by trypan blue exclusion or morphol-
ogy. This result is consistent with mitochondria being
the source of the increase in ROS. Rotenone and anti-
mycin A, 2 other mitochondrial respiratory chain inhib-
itors, were also evaluated, but as previously noted,19 both
of these inhibitors greatly increased ROS production in
control cells and thus were not useful for determining the
source of core-induced ROS.
Figure 2. HCV core protein expression increases cellular ROS levels.
(A) ROS was measured as single-cell fluorescence after exposure of
cells to CM-DCF for 2 hours. Results are expressed as relative bright-
ness and normalized to control cells. Huh-7/191-20 cells were incu-
bated for 72 hours with (off, n 5 1114) or without (on, n 5 1140)
tetracycline. Parental Huh-7 cells were cultured under control condi-
tions (C, n 5 180) or for 2 hours in the presence of tumor necrosis
factor a (30 ng/mL) and actinomycin D (0.5 mg/mL; T; n 5 32). Core
protein–inducible HeLa/191-14 cells (off, n 5 514; on, n 5 514) and
stably transfected CHO-K1 cells expressing core/E1/E2 proteins
(core, n 5 2861) or E1/E2 proteins (E, n 5 2950) were also used as
indicated. (B) Total cellular lipid peroxidation products, 4-hydroxyalk-
enals (4-HNE) and malondialdehyde (MDA), were determined by col-
orimetric lipid peroxidation assay (LPO-586) from cellular extracts.
Induction of core protein expression resulted in a 2-fold elevation in
lipid peroxide products in both Huh-7 and HeLa cells (P , 0.05). The
experiment was repeated 4 times in Huh-7 cells and 8 times in HeLa
cells.
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We next examined whether the MPT plays a role in
core protein–induced accumulation of ROS. Cells were
loaded with a fluorescent organic cation, rhodamine-123,
which is accumulated in mitochondria as a result of the
negative intramitochondrial potential. The onset of MPT
was determined by the sudden loss of rhodamine-123
fluorescence from mitochondria. Spontaneous MPT did
not occur within 8 hours of observation, and core protein
expression by itself did not induce MPT by this assay.
MPT was next induced by continuous exposure of cells to
t-butylhydroperoxide (tBOOH, 25 mmol/L). In control
cells, MPT occurred after a period of 2.1 6 0.2 hours
(n 5 38). Expression of core protein had no effect on the
sensitivity or time required for tBOOH-induced MPT.
Permeability transition was significantly delayed by the
presence of the MPT inhibitor cyclosporin A (2.9 6 0.3
hours, n 5 32; P , 0.001). Despite its ability to delay
MPT, cyclosporin A had no effect on the core-induced
increase in ROS abundance (Figure 3B). This suggests
that MPT does not play a role in the accumulation of
ROS associated with core protein expression.
Association of Core Protein
With Mitochondria
Because these results suggest the possibility of a
direct effect of core protein on mitochondrial function,
the spatial relationship between core protein and mito-
chondria was determined by fluorescence microscopy.
Figure 4 shows the relationship between indirect immu-
nofluorescence for core protein (green) and mitochondria
(stained with MitoTracker Red). Epifluorescence images
(Figure 4A–C ) show that core protein is expressed in a
vesicular pattern that is largely distinct from the more
filamentous mitochondria. However, there were numer-
ous areas of overlap between mitochondria and the core
protein, particularly in the perinuclear region. We fur-
Figure 4. Intracellular distribution of HCV-core protein. Huh-7/191-20
cells were grown in the absence of tetracycline, stained with Mito-
Tracker Red for mitochondria, DAPI (blue) for nuclei, and indirect
immunofluorescence (green) for core protein and examined by (A, B,
C) epifluorescence or (D, E, F) confocal microscopy. Images of (A, D)
core protein and (B, E) mitochondria are shown. In the composite of
both images (C, F), areas of colocalization appear as a yellow color.
The depth of field for the confocal images is 1.0–1.5 mm. (G) Immu-
noblotting for HCV core protein, an intrinsic mitochondrial protein
(cytochrome oxidase, cox II), and an ER protein (calnexin) were per-
formed in crude and pure mitochondrial fractions as described. The
expected molecular weights are indicated.
Figure 3. Mitochondria are the source of core-induced ROS. (A) DPI
(100 mmol/L) was added to the HCV core protein–expressing (n 5
637) and –nonexpressing (n 5 600) Huh-7 cells for 3 hours. (B)
Cyclosporin A (Cyc A, 5 mmol/L) was added to the on (n 5 355) and
off (n 5 370) cells for 20 hours before measurement of ROS
content.
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ther examined the possibility of colocalization using
confocal microscopy producing images with a depth of
field of 1.5 mm (Figure 4D, E). These images show
colocalization of core and mitochondria in several loca-
tions, particularly in the perinuclear location.
To further evaluate the possibility that core protein
associates with mitochondria, we determined the distri-
bution of core among subcellular fractions. In Huh-7/
191-20 cells, most of the core protein was present in
a crude mitochondrial fraction (Figure 4G), whereas no
core protein was detectable in the cytosol (data not
shown). However, immunoblot analysis of the crude
mitochondrial fraction with antibodies specific for caln-
exin (an endoplasmic reticulum [ER] protein) and cyto-
chrome oxidase (an intrinsic mitochondrial protein)
showed substantial ER contamination. Further purifica-
tion of the mitochondria on a discontinuous Percoll
gradient13 successfully eliminated ER contamination,
but core protein remained associated with the mitochon-
dria (Figure 4G).
Core Protein Effects on Cytochrome c
Distribution
We next examined the effects of core protein
expression on the intracellular distribution of cyto-
chrome c. The release of cytochrome c from mitochondria
can occur before or as a consequence of the mitochondrial
permeability transition and may subsequently trigger the
downstream events of apoptosis. We assessed the cyto-
chrome c content of mitochondrial and cytosolic fractions
prepared from Huh-7/191-20 and HeLa/191-14 cells
(Figure 5A ). In the presence of tetracycline (core expres-
sion off), there was minimal or no detectable cytochrome
c in the cytosol. In both cell types, cytochrome c was
increased in the cytosol on withdrawal of tetracycline
(core expression on). Figure 5B shows the fraction of
cellular cytochrome c that was recovered in the cytosolic
fraction, as determined by densitometric analysis of im-
munoblots. The increase in cytosolic cytochrome c ac-
companying the expression of core was statistically sig-
nificant in both Huh-7 (P , 0.01) and HeLa (P , 0.05)
cells. However, most cellular cytochrome c remained in
the mitochondrial fraction under these conditions.
Changes in Cellular Antioxidant Gene
Expression With Induction of Core Protein
Because the relatively high levels of ROS accu-
mulating in Huh-7/191-20 cells expressing the core
protein were not associated with changes in the viability
of these cells, we considered the possibility that antiox-
idant defense mechanisms might be induced. This hy-
pothesis was examined by measuring the relative abun-
dance of cellular RNA transcripts before and 72 hours
after the induction of core protein using Affymetrix
oligonucleotide microarrays containing 12,263 individ-
ual probe sets for human mRNAs. Comparison of gene
expression patterns between cells expressing and not
expressing HCV core showed that only 35 mRNAs were
differentially regulated $3-fold. Analysis of the identity
of these gene products showed that 9 (26%) occurred in
genes encoding proteins potentially involved in antioxi-
dant defense (Table 1). The 2 mRNAs that were most
increased in abundance encoded metallothionein 1A (65-
fold) and metallothionein 1X (27-fold). These proteins
have been shown in vitro to protect cells against oxida-
tive damage.20 The Affymetrix results were confirmed by
Figure 5. Distribution of cytochrome c in mitochondrial and cytosolic
fractions. (A) Immunoblots for cytochrome c were performed on mito-
chondrial and cytosolic fractions derived from Huh-7/191-20 and
HeLa/191-14 cultured in the presence or absence of tetracycline. (B)
The ratio of cytochrome c concentration in cytosolic/mitochondrial
fraction was measured by densitometry and corrected for the different
amounts of protein applied to each lane. Results are expressed for
each cell type before and after induction of core expression. *P ,
0.01; **P , 0.05.
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independent, semiquantitative reverse-transcription poly-
merase chain reaction assays for these mRNAs (data not
shown). Similar changes in metallothionein mRNA abun-
dance were not observed in normal Huh-7 cells on with-
drawal of tetracycline from the media.
Hepatic Lipid Peroxidation in Transgenic
Mice Expressing HCV Structural Proteins
To determine the relevance of these cell culture
observations to an animal model of chronic hepatitis
C, we examined the response to oxidative stress in
S-N/863 transgenic mice that express the HCV struc-
tural proteins (core, E1, and E2p7) under control of
the liver-specific albumin promoter. These mice are
immunotolerant to proteins expressed from the HCV
transgene and show no evidence of intrahepatic in-
flammation, but male animals in the lineage have a
high incidence of hepatic steatosis (Lerat et al.). To
determine whether these mice are more vulnerable to
oxidative injury than normal mice, we determined
liver histology, hepatic lipid peroxidation, and alanine
aminotransferase 24 hours after administering a low
dose of CCl4 intraperitoneally. This low dose of CCl4
produced small foci of centrilobular necrosis with
ballooning degeneration of hepatocytes and elevated
alanine aminotransferase in both normal and trans-
genic animals. These effects are typical of CCl4-in-
duced liver injury.21 In transgenic animals, there was
a 2-fold increase in total hepatic lipid peroxidation
products (Figure 6). In contrast, although nontrans-
genic littermates sustained a similar histologic injury,
they showed no appreciable increases in hepatic lipid
peroxides (P , 0.05). These results show that HCV
transgenic animals are abnormally vulnerable to oxi-
dant stress and that expression of the structural pro-
teins, including the core protein, results in a tendency
to develop lipid peroxidation in vivo similar to that
described previously for stably transformed cell lines.
Discussion
This study used 2 different inducible cell culture
systems to show that expression of the HCV core protein
directly produces oxidative stress. This effect is blocked
by an inhibitor of mitochondrial electron transport, and
core protein itself localizes in mitochondria. Several pos-
sible mechanisms could explain a core-induced change in
mitochondrial function. One explanation is that core
protein alters signal transduction pathways that promote
the mitochondrial permeability transition. Core protein
is known to bind to the cytoplasmic domains of the
lymphotoxin-b receptor22 and tumor necrosis factor re-
ceptor 1.23 Oligomerization of each of these receptors
initiates a signaling cascade that involves activation of
caspase 8, proteolytic activation of Bid, and translocation
of activated Bid from cytosol to mitochondria. This
results in mitochondrial permeability transition, release
of cytochrome c, and ultimately cellular apoptosis.24
Many viruses have the ability to modulate apoptosis in
their host cells, and both suppression and induction of
apoptosis can be beneficial to the virus in promoting
replication, persistence, and dissemination.25 The mito-
chondrial permeability transition is a key target for viral
modulation of apoptosis. Several viral protein interact
with Bcl-2 family proteins to suppress apoptosis. Exam-
ples of this are the HSV1 Us3 protein,26 the HTLV-1
Tax protein,27 and the HVS Bcl-2 analog protein.28 Viral
proteins can also activate apoptosis by multiple mecha-
nisms. In particular, the human immunodeficiency virus
1 protein Vpr has been shown to interact directly with
the mitochondrial permeability transition pore complex
Figure 6. HCV structural protein expression sensitized oxidative
stress in HCV transgenic mice. Lipid peroxide content was measured
in liver homogenates 24 hours after injection of carbon tetrachloride
(CCl4) or olive oil (C) intraperitoneally to either control (non-TgM,
n 5 4) or HCV transgenic mice (TgM, n 5 5). **P , 0.05.
Table 1. Up-Regulation of Antioxidant Genes in Huh-7/191-
20 Cells 72 Hours After Removal of Tetracycline
Gene name Fold induction GenBank ID
Metallothionein-1A 65.2 K01383
Metallothionein-1X 27.5 AA224832
Metallothionein-1F 6.8 M10943
Homo sapiens cDNA similar to MT-1F 5.4 H68340
Metallothionein-1H 5.2 R93527
Metallothionein-1E 4.7 R92331
Metallothionein-1B 4.2 M13485
Metallothionein-3 3.5 M93311
Glutathione peroxidase-like protein 3.4 X53463
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producing cytochrome c release and apoptosis.29 HCV
core protein has itself been previously implicated in the
modulation of apoptosis, although the reports of this
phenomenon have observed both proapoptotic23,30,31 and
antiapoptotic32–34 effects.
Our data suggest that direct activation of MPT is not
the mechanism of the HCV core protein effects. We did
not observe any increase in apoptosis in the core express-
ing cells, and they did not spontaneously undergo MPT.
Furthermore, as shown in Figure 3B, the abnormal ROS
accumulation was not blocked by treatment with cyclo-
sporin A, an inhibitor of the mitochondrial permeability
transition. Increased MPT and apoptosis is thus not the
explanation for the observed increase in ROS induced by
core protein. Other evidence also suggests that changes
in signaling to the mitochondria are not the primary
effect of core protein. In a recent study in transgenic
mice, Machida et al.32 observed no change in caspase 8 or
Bid activation resulting from expression of HCV proteins
in the liver. In preliminary studies, we also did not
observe any effect of core protein on the activation state
or subcellular localization of Bid, and the treatment of
cells with the nonspecific caspase inhibitor z-VADfmk
did not prevent the core-associated increase in ROS (data
not shown). This evidence suggests that core-induced
ROS production is not a consequence of caspase-medi-
ated signaling to the mitochondria.
An alternative hypothesis is that the core protein
interacts directly with mitochondria, impairing electron
transport, and thereby increasing ROS production. Core
protein has been previously demonstrated to be associ-
ated with the ER35 and intracellular lipid droplets.36,37
In our Huh-7/191-20 cells, core protein colocalized with
perinuclear mitochondria, was present in purified mito-
chondria and ER fractions, and was expressed in struc-
tures adjacent to the mitochondria as well (Figure 4).
Immunoelectron microscopy in core protein transgenic
mice has also shown an association of core protein with
mitochondria.38 Close interactions of ER and mitochon-
dria have also been observed in other cells and may
contribute to regulation of the intramitochondrial cal-
cium concentration.39
Our evidence does not directly show a functional effect
of core protein on mitochondria, but it suggests that
mitochondria are the major source of the ROS because
DPI, an inhibitor of electron transport in flavoenzymes,
completely abolished the core-induced increment in ROS
content. This inhibitor, which was not toxic to our cells
under these conditions, blocks mitochondrial complex I
at a proximal site and has been shown to prevent almost
all mitochondrial ROS production.40 However, DPI can
also inhibit ROS production from microsomal NADPH
oxidase. Two other mitochondrial electron transport
inhibitors, rotenone, a distal complex I inhibitor, and
antimycin A, a complex III inhibitor, increase mitochon-
drial ROS production by themselves19 and thus could
not provide information on the source of the core-in-
duced ROS. Nonetheless, because mitochondria are the
major source of cellular ROS and core protein directly
interacts with mitochondria, these data suggest a mito-
chondrial source of core-induced ROS.
We observed an increase in the cytochrome c content
of cytosolic fractions from core-expressing cells (Figure
4). Because the core-expressing cells did not undergo
increased apoptosis or MPT, this increase in cytochrome
c release could represent a change in mitochondrial fra-
gility induced by core protein, which causes more mito-
chondrial disruption to occur in the isolation procedure.
Our findings contrast with those of Machida et al.,32 who
observed that HCV proteins inhibited Fas-mediated cy-
tochrome c release in transgenic mice. Several important
differences in the 2 experimental systems may explain
these results. In the present study, cytochrome c was
determined in cell cultures expressing core protein only.
In the previous study,32 transgenic mice were expressing
not only core protein but E1, E2, and NS2 as well. In
addition, the effects observed in our study occurred with-
out provocation, and the previous study examined cyto-
chrome c release induced by an anti-Fas antibody.32 The
magnitude of release in our study is relatively small and
potentially could be overshadowed by stimuli that rap-
idly induce apoptosis.
Our observations suggest a new model for the patho-
genesis of chronic hepatitis C, as illustrated schemati-
cally in Figure 7. An increased abundance of ROS occurs
as a direct result of core protein expression. This is likely
to further impair mitochondrial electron transport, am-
plifying the effect of core on the mitochondria and
sensitizing cells to other oxidative insults. Such a posi-
Figure 7. Model for the role of mitochondrial ROS production in
pathogenesis of hepatitis C.
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tive feedback effect of ROS on mitochondrial ROS gen-
eration is well documented.41 Cells use a number of
antioxidant mechanisms to respond to these circum-
stances, including induction of antioxidant proteins that
contribute to cell survival. Antioxidant gene expression
could explain some of the divergent effects of core pro-
tein on apoptosis seen in other experiments.30,32 Differ-
ent cells are likely to respond to the core-induced ROS
increase in different ways. In our Huh-7/191-20 line,
there is a dramatic induction of antioxidant gene expres-
sion. Core protein has been shown to activate antiapop-
totic factors such as NF-kB.42 This could have a net
effect that suppresses apoptosis. In cells that fail to
activate antioxidant genes or NF-kB, core protein–in-
duced ROS production may sensitize cells to apoptosis.
What is consistent is that core protein expression in-
creases cellular ROS. This interpretation is further sup-
ported by the recent report of Moriya et al.,43 who have
demonstrated that HCV core protein causes a state of
oxidative stress in transgenic mice.
The maximal quantity of core protein expressed in our
cell system is greater than that seen in liver tissue of
infected humans, and it might therefore be argued that
core protein plays no role in oxidative stress in human
disease. However, core protein can be detected in immu-
noblots of infected human liver.44 Our transgenic mice
also show oxidative effects of core protein, but expression
can be detected only by immunofluorescence and not by
the somewhat less sensitive immunoblots ( J. Sun, per-
sonal communication, June, 2001). Therefore, core pro-
tein produces oxidative stress in the range of concentra-
tions found in infected human liver.
The consequences of this state of chronic oxidative
stress include a reduction in mitochondrial metabolic
processes, which might contribute to the development of
steatosis by inhibition of b-oxidation and oxidative dam-
age to both mitochondrial and chromosomal DNA. The
combination of oxidative DNA damage and suppression
of apoptosis favors the development of hepatocellular
carcinoma. Recent observations in transforming growth
factor a/c-myc mice show that chronic oxidative stress
promotes hepatic tumor formation and that this can be
prevented by antioxidant therapy.45 The consequences of
impaired mitochondrial function and abnormal ROS
generation would be exacerbated by the immune-medi-
ated inflammatory process present in patients with
chronic hepatitis C, and the additional oxidant load it
would present to the HCV-infected liver.
Given the demonstration that core protein directly
induces oxidative stress, further understanding of the
mechanisms of core protein’s interactions with the mi-
tochondria could lead to new therapeutic approaches to
this widespread chronic disease.
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